CV

CapsoVision, Inc CV

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,740 of 2,925

Why it scores 21Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$3.64M

Quarter to Jun 30

Net income

$-7.48M

Quarter to Jun 30

Free cash flow

$-8.40M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$38.62M total
BlackRock, Inc.
$14.37M+45.4%
VANGUARD CAPITAL MANAGEMENT LLC
$8.02M+3.1%
GEODE CAPITAL MANAGEMENT, LLC
$4.39M+32.9%
STATE STREET CORP
$3.11M+60.2%
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.82M+46.3%
NORTHERN TRUST CORP
$1.67M+44.5%
VANGUARD FIDUCIARY TRUST CO
$785.5K+16.9%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$601.5K+29.3%
Bank of New York Mellon Corp
$568.7K+52.2%
Nuveen, LLC
$348.8K+39.0%
DEUTSCHE BANK AG\
$263.0K+37.2%
XTX Topco Ltd
$241.4K-52.7%
WELLS FARGO & COMPANY/MN
$241.2K+210.6%
PRICE T ROWE ASSOCIATES INC /MD/
$221.0K+48.5%
BANK OF AMERICA CORP /DE/
$193.1K+14.5%
RHUMBLINE ADVISERS
$166.5K+67.3%
MetLife Investment Management, LLC
$160.0K+26.4%
Invesco Ltd.
$142.7KNew
MORGAN STANLEY
$141.9K+25.4%
GOLDMAN SACHS GROUP INC
$141.2K-48.4%
CITIGROUP INC
$124.2K+3965.5%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
$121.8K+23.1%
JPMORGAN CHASE & CO
$109.8K+28.7%
Russell Investments Group, Ltd.
$109.5K+555.0%
Police & Firemen's Retirement System of New Jersey
$100.6K+90.8%
See all 50 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CV

Earnings Per Share

13fpro.ai/company/CV

Loading ratio trend…

CV key financials by period

Reported revenue, net income and operating margin by fiscal year, from CapsoVision, Inc's annual filings on SEC EDGAR.

CapsoVision, Inc reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$13.6M$-25.3M-188.3%
FY 2024$11.8M$-19.9M-169.4%
Source: CV filings on SEC EDGAR →

CV insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About CapsoVision, Inc (CV): stock profile, AI score and financials

CapsoVision, Inc (CV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CV at 20.9/100 on a composite quality score built from its SEC filings, placing it at rank #2,740 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), CapsoVision, Inc reports quarterly revenue of $3.6M, net income of $-7.5M, free cash flow of $-8.4M. Top institutional holders of CV by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. CV trades on the Nasdaq exchange and files with the SEC under CIK 1378325. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CapsoVision, Inc directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1378325 →